Skip to main content

Table 2 Colonoscopy characteristics depending on participating reference hospital. Results are expressed as n (%)

From: Appropriateness of colonoscopy requests according to EPAGE-II in the Spanish region of Catalonia

Ā 

Total (nā€‰=ā€‰1478)

H1 (nā€‰=ā€‰245)

H2 (nā€‰=ā€‰245)

H3 (nā€‰=ā€‰250)

H4 (nā€‰=ā€‰250)

H5 (nā€‰=ā€‰247)

H6 (nā€‰=ā€‰241)

P

Prioritya

Ā Ā Ā Ā Ā Ā Ā 

<0,001

ā€ƒRoutine

919 (69.72Ā %)

171 (73.7Ā %)

195 (89.9Ā %)

70 (49.0Ā %)

221 (89.5Ā %)

129 (53.3Ā %)

133 (56,1Ā %)

Ā 

ā€ƒPreferential

235 (24.65Ā %)

47 (20.3Ā %)

8 (3.69Ā %)

45 (31.5Ā %)

17 (6.88Ā %)

76 (31.4Ā %)

42 (17,7Ā %)

Ā 

ā€ƒUrgent

164 (17.20Ā %)

14 (6.03Ā %)

14 (6.45Ā %)

28 (19.6Ā %)

9 (3.64Ā %)

37 (15.3Ā %)

62 (26,2Ā %)

Ā 

Indication

Ā Ā Ā Ā Ā Ā Ā 

0,019

ā€ƒDiagnostic suspicion

953 (64.47Ā %)

164 (66.9Ā %)

152 (62.0Ā %)

156 (62.4Ā %)

165 (66.0Ā %)

152 (61.5Ā %)

164 (68,0Ā %)

Ā 

ā€ƒFollow-up

355 (24.01Ā %)

59 (24.1Ā %)

53 (21.6Ā %)

66 (26.4Ā %)

47 (18.8Ā %)

70 (28.3Ā %)

60 (24,9Ā %)

Ā 

ā€ƒOpportunistic screening

170 (11.50Ā %)

22 (8.98Ā %)

40 (16.3Ā %)

28 (11.2Ā %)

38 (15.2Ā %)

25 (10.1Ā %)

17 (7,05Ā %)

Ā 

Type of diagnostic suspicionb

Ā Ā Ā Ā Ā Ā Ā 

0,012

ā€ƒRectal bleeding

357 (37.46Ā %)

53 (32.3Ā %)

60 (39.5Ā %)

55 (35.3Ā %)

71 (43.0Ā %)

60 (39.5Ā %)

58 (35,4Ā %)

Ā 

ā€ƒAbdominal pain

253 (26.54Ā %)

48 (29.3Ā %)

42 (27.6Ā %)

37 (23.7Ā %)

36 (21.8Ā %)

32 (21.1Ā %)

58 (35,4Ā %)

Ā 

ā€ƒAnaemia

160 (16.78Ā %)

30 (18.3Ā %)

21 (13.8Ā %)

32 (20.5Ā %)

27 (16.4Ā %)

26 (17.1Ā %)

24 (14,6Ā %)

Ā 

ā€ƒChanges in bowel habit

76 (7.97Ā %)

20 (12.2Ā %)

13 (8.55Ā %)

18 (11.5Ā %)

13 (7.88Ā %)

10 (6.58Ā %)

2 (1,22Ā %)

Ā 

ā€ƒOther

107 (11.22Ā %)

13 (7.93Ā %)

16 (10.5Ā %)

14 (8.97Ā %)

18 (10.9Ā %)

24 (15.8Ā %)

22 (13,4Ā %)

Ā 

Type of follow-upc

Ā Ā Ā Ā Ā Ā Ā 

<0,001

ā€ƒAdenomas

205 (58.07Ā %)

22 (37.9Ā %)

34 (64.2Ā %)

37 (56.9Ā %)

37 (78.7Ā %)

32 (45.7Ā %)

43 (71,7Ā %)

Ā 

ā€ƒCRC

110 (31.16Ā %)

29 (50.0Ā %)

14 (26.4Ā %)

19 (29.2Ā %)

6 (12.8Ā %)

35 (50.0Ā %)

7 (11,7Ā %)

Ā 

ā€ƒUlcerative colitis

16 (4.53Ā %)

3 (5.17Ā %)

3 (5.66Ā %)

2 (3.08Ā %)

2 (4.26Ā %)

2 (2.86Ā %)

4 (6,67Ā %)

Ā 

ā€ƒCrohnā€™s disease

7 (1.98Ā %)

1 (1.72Ā %)

0 (0.00Ā %)

5 (7.69Ā %)

0 (0.00Ā %)

1 (1.43Ā %)

0 (0,00Ā %)

Ā 

ā€ƒDiverticular disease

3 (0.85Ā %)

0 (0.00Ā %)

1 (1.89Ā %)

0 (0.00Ā %)

0 (0.00Ā %)

0 (0,00Ā %)

2 (3,33Ā %)

Ā 

ā€ƒOther

12 (3.40Ā %)

3 (5.17Ā %)

1 (1.89Ā %)

2 (3.08Ā %)

2 (4.26Ā %)

0 (0,00Ā %)

4 (6,67Ā %)

Ā 
  1. aover the total (missing cases excluded)
  2. bOver diagnostic suspicion indication
  3. cOver follow-up indication
  4. CRC Colorrectal cancer